









Markets
/
Stocks
/
nasdaq-actu
/

Actuate Therapeutics Inc

ACTU

2.290USD

+0.020+0.88%

Market hours （ET）Quotes delayed by 15 min

43.77MMarket Cap

LossP/E TTM



Actuate Therapeutics Inc

2.290

+0.020+0.88%

Overview Financials Analysis Company

Overview

Financials

Analysis

Company

Cash Flow Statement

You can access the annual and quarterly cash flow statements of Actuate Therapeutics Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

21.72%-3.74M

27.01%-6.68M

-56.11%-4.17M

11.98%-4.62M

---4.77M

---9.15M

---2.67M

2.08%-5.25M

---5.36M

Net income from continuing operations

29.35%-4.55M

9.44%-5.41M

9.48%-5.95M

23.86%-6.32M

---6.45M

---5.97M

---6.57M

-57.41%-8.30M

---5.27M

Other non-cash items

--0.00

104.42%15.19K

----

--0.00

---343.24K

----

Change in working capital

-250.13%-723.76K

30.76%-2.99M

-92.82%191.31K

-75.95%568.12K

--482.09K

---4.32M

--2.66M

1376.66%2.36M

---185.07K

-Change in prepaid expenses

-79.64%35.24K

40.27%-323.33K

308.76%163.26K

349.94%207.12K

--173.05K

---541.35K

---78.20K

-1679.92%-82.87K

--5.25K

-Change in other current assets

100.00%0.00

--0.00

--110.55K

---110.55K

----

-Change in other current liabilities

-0.28%5.06K

11.96%15.19K

----

--0.00

--5.08K

--13.56K

----

Cash from non-recurring investing activities

Cash from operating activities

21.72%-3.74M

27.01%-6.68M

-56.11%-4.17M

11.98%-4.62M

---4.77M

---9.15M

---2.67M

2.08%-5.25M

---5.36M

Investing cash flow

Cash from non-current investing activities

Financing cash flow

Cash flow from continuous financing activities

73.22%-29.30K

-23.35%17.11M

608.12%6.78M

-103.06%-133.48K

---109.41K

--22.32M

--957.04K

76.88%4.36M

--2.46M

Net cash flow from debt Issuance/repayment

--0.00

-100.00%0.00

--0.00

--1.00M

--4.50M

--0.00

Net cash flow from common stock issuance/repurchase

--0.00

-28.05%17.24M

--2.16M

----

--0.00

--23.96M

----

Net cash flow from preferred stock issuance/repurchase

----

--0.00

-100.00%0.00

--2.46M

Proceeds from stock option exercised by employees

--0.00

--34.12K

----

Net cash flow from other financing activities

73.22%-29.30K

92.21%-127.39K

10760.61%4.58M

6.51%-133.48K

---109.41K

---1.64M

---42.96K

---142.77K

--0.00

Net cash from non-recurrent financing activities

Net cash from financing activities

73.22%-29.30K

-23.35%17.11M

608.12%6.78M

-103.06%-133.48K

---109.41K

--22.32M

--957.04K

76.88%4.36M

--2.46M

Net cash flow

Beginning cash balance

----

1746.03%6.49M

88.05%3.89M

192.08%8.64M

--13.52M

--351.71K

--2.07M

-85.53%2.96M

--20.45M

Current period cash flow changes

22.87%-3.77M

-20.80%10.43M

251.65%2.60M

-433.75%-4.75M

---4.88M

--13.17M

---1.72M

69.25%-890.35K

---2.90M

Ending cash balance

52.28%13.16M

25.15%16.92M

1746.03%6.49M

88.05%3.89M

--8.64M

--13.52M

--351.71K

-88.22%2.07M

--17.55M

Currency unit

USD

Audit opinions

FAQs

What is the cash flow statement?



This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.

KeyAI

